Tokyo, March 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060999) titled 'Effect of pharmacist-led educational intervention on switching to generic medicine among patients using brand-name medicines' on March 20.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control

Primary Sponsor: Institute - Other

Condition: Condition - Patients using brand-name medicines Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aimed to investigate whether patients using brand-name medicines, who had limited knowledge and low perception of generic medicine, would switch from brand-name medicines to generic medicine following pharmacist-led educational intervention. Additionally, we compared the knowledge and perceptions of generic medicine before and after the intervention and assessed whether these findings contributed to an increase in the number of patients switching from brand-name medicines to generic medicine. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - In this study, the educational intervention consisted of pharmacists providing standardized explanations using pamphlets about generic medicine (GE) to patients who preferred brand-name medicines and allocating time to answer questions. The content covered GE's manufacturing approval processes, efficacy, quality, safety, advantages not present in brand-name medicines [e.g., improved bitterness and dosing convenience], economic benefits of using GE, the background of GE promotion policies, and fees related to patient preference for brand-name medicines. The standardized explanation and Q&A sessions were scheduled to take approximately 20 min. The intervention was scheduled for the second visit.

Eligibility: Age-lower limit - 18 years-old

Gender - Male and Female Key inclusion criteria - Patients who have provided informed consent to participate in this study Patients who have previously used generic medicines Patients aged 18 to 74 who are using one or more brand-name medicines of their own request Key exclusion criteria - Patients who wish to use generic medicines for all prescribed medications Patients who have no prior experience with generic medicines Patients who were unable to complete all procedures for VISIT 1 and 2 in accordance with the protocol Patients taking medications to improve cognitive function who were deemed unsuitable due to a lack of understanding regarding the medications Patients taking psychotropic medications, such as antidepressants or antipsychotics, who were deemed unsuitable due to the high likelihood of causing excessive distress Target Size - 50

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2025 Year 02 Month 07 Day Date of IRB - 2025 Year 02 Month 07 Day Anticipated trial start date - 2025 Year 03 Month 01 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069805

Disclaimer: Curated by HT Syndication.